Shining light on the brain: The 2026 Nobel Prize in Medicine

What if we could switch a single brain cell on or off just using a flash of light, the way we switch on or off a light bulb? Though it sounds like science fiction, it is an established experimental method, especially in neuroscience laboratories worldwide. On 5 October 2026, this method earned the Nobel Prize in Physiology or Medicine.

The prize went to an American neuroscientist, Karl Deisseroth, and two Germans, Peter Hegemann and Georg Nagel , 'for their discoveries concerning light-gated ion channels and optogenetics'. But remarkably, the story of this discovery begins not with brains, but with an ubiquitous alga, known to form the so-called 'pond scum'.

Chlamydomonas is a single-celled green alga that swims using two whip-like flagella. Like plants, they do photosynthesis and need sunlight to live. They steer towards light using a small orange 'eyespot'. Peter Hegemann, a German neuroscientist and biophysicist currently a faculty member at Humboldt University of Berlin, spent much of his career asking how a cell without eyes, nerves, or a brain can detect light. He was interested in the question right from his PhD years, when he studied the structure and function of 'halorhodopsin', a light-senstive protein found in archaea that uses light energy to move chloride ions into the cells. His discovery of a similar protein in the cell membrane of the alga Chlamydomonas helped explain the curious case of light-directed movements in algae.

Every cell is wrapped in a membrane that keeps different positively and negatively charged ions, mostly in or out, maintaining a balance required for a living cell. There are proteins called 'ion channels' that act as gates that let specific ions through. In 2002, Hegemann, then a faculty member in the department of Biochemistry at the University of Regensburg, in collaboration with George Nagel, from the Max Planck Institute of Biophysics in Frankfurt and other colleagues, showed that the alga's light sensor is itself such a gate for ions on the cell membrane. When blue light hits this protein, the channel snaps open and positive ions rush into the cell. Aptly, they named it 'channelrhodopsin'. George Nagel further proved this by placing the gene into frog egg cells, which then started responding to light too.

But how is the algal light-sensitive protein related to a science-fiction-like experimental tool in neuroscience?

Neurons in the brain communicate with each other via electrical signals called action potentials, that are produced by ions flowing through channels in the neuron's membrane and thus creating an imbalance that spreads along the cell membrane. The signal propagates to a neighbouring membrane across the nerve terminals, forming the so-called 'synapses', where information is transferred by biochemical mediators called neurotransmitters. Once the signal reaches the next neuron's membrane, the action potential takes over again to transmit the information.

Karl Deisseroth, a cognitive neuroscientist at Stanford University, saw a great opportunity when channelrhodopsin was discovered. In 2005, Deisseroth and his team introduced the gene for channelrhodopsin into rat neurons growing in a dish. The neurons began making the algal protein and a pulse of blue light made them fire, with millisecond precision.

This method became known as optogenetics: 'opto-' for the use of light and '-genetics' for the gene that makes it work. Researchers soon discovered and used other light-sensitive proteins that can actually do the opposite, i.e. silencing neurons when lit up. With thin optical fibres implanted in the brains of living mice to transmit light of a specific wavelength, scientists could switch chosen cells on and off while the animal moved freely.

The human brain has roughly 86 billion neurons of many different types, tangled together and working in groups or networks. Older tools, such as electrodes or drugs, when used, affected many cells at once. Optogenetics lets scientists target any specific cell type in a brain region at the exact moment they choose. This lets researchers switch on a specific neural circuit in a living experimental animal at will, then follow the resulting behavioural and functional changes.

Using this approach, researchers have made extremely important discoveries, for example, tracing the neural circuits involved in fear, reward, memory, sleep and movement. It has greatly enriched our understanding of neurological conditions such as Parkinson's disease, depression and addiction.

The first steps toward using the principle to treat diseases are already visible. In 2021, a study done at the department of Ophthalmology, University of Basel, Switzerland, reported how a man blinded by the inherited eye disease retinitis pigmentosa partly regained sight. Researchers gave his remaining retinal cells a light-sensitive channelrhodopsin called ChrimsonR, then used special goggles to project images onto them. While it was really a preliminary study, it shows the idea can reach patients.

Finally, this year's Nobel Prize reiterates the importance of pure, curiosity-driven scientific pursuits. None of the scientists studying how the 'pond scum' algae swim towards sunlight was trying to cure blindness or map the brain. This year's prize is a great reminder that an insatiable curiosity about apparently 'nonutilitarian' questions often produces the most useful knowledge and tools for the humanity.